In a luminal B experimental PyVmT model, c-Src was shown to stimulate the phosphorylation and activation of FOXM1, and targeting FOXM1 with the FOXM1 inhibitors blocked the cell cycle and tumor initiation, as well as tumor progression [28]. This evidence concerns the gene SRC and neoplasm.